DIA CoRE Singapore Annual Meeting 2022 is set to unravel from 12-13 July 2022 on account of the 5th-year anniversary. This meeting offers a neutrally organized forum to discuss lessons learned during the pandemic and better prepare the healthcare system for the next challenges.

Representatives from regulatory agencies, health authorities (Ali Al dalaan,[SFDA] Wen-Yi Hung[TFDA] Shin-ichi Okudaira [PMDA]) Jesusa Joyce N. CIRUNAY [Philippines FDA] and industry leaders (Serena Chan [Syneos Health], Daniela Caiazza [Novotech], Ralf Altenburger[Roche], Yu LIANG [MSD], and many more) meet in person for the first time in two years to foster positive changes in the healthcare environment in the Asia-Pacific. That includes emerging technologies, innovations in cancer care, digital health, and improved patient access to novel therapies. 

Sessions will be discussing Digital Health, Decentralized Clinical Trials, access to innovative Therapies, dynamics of decentralised clinical trials, novel approaches for managing cancer care from innovative cell and gene therapies, country-specific regulations, building regulatory agility for improved patient access, regulatory convergence, and many more topics with industry leaders.

Connecting different perspectives and interests in a neutral forum allows open dialogue and facilitates solutions and concrete action points for today's healthcare challenges, such as, "Fostering digital health adoption in the Asia-Pacific is highly dependent on regulatory frameworks. The session will discuss the benefits of digital health, personalised care, and what is necessary to improve the application in the region".

Empowering the ASEAN patients is the subject of a town hall format, where all participants wrap up the conference and discuss the efficiency and sustainability of healthcare systems in ASEAN and identify the next steps.